Increased viral load in a hospitalized patient on treatment with crushed bictegravir/emtricitabine/tenofovir alafenamide: A case report and review of the literature

CONCLUSION: Controlled studies are needed to verify acceptable pharmacokinetic and pharmacodynamic metrics for crushed B/FTC/TAF given via tube, with and without tube feeds, before use in this manner.PMID:35511892 | DOI:10.1093/ajhp/zxac120

Source: American Journal of Health-System Pharmacy : AJHP - May 5, 2022 Category: Drugs & Pharmacology Authors: Sarah M Rowe Jackson C Clary Malashia Drummond Caroline Derrick Kamla Sanasi P Brandon Bookstaver Source Type: research